The Canadian Liver Journal 9.1 presents notes from the Annual Canadian Liver Meeting 2026 of the Canadian Association for the Study of the Liver, the Canadian Network on Hepatitis C and CanMASLD.
Learn more: https://bit.ly/CanLivJ91k
#Hepatitis #Cirrhosis #MASLD
I teach medical students that fatty liver disease (MASLD) affects 1 in 3 adults and has limited approved drug treatments.
That may be changing.
Hebrew University researchers fo... www.sciencedaily.com/releases/2026/03/2603061...
#FattyLiver #MASLD #CBD #MetabolicHealth #LiverDisease
🔥HOT TOPIC in #HEPATOLOGY
Selected for its clinical impact, this meta-analysis delivers critical insights into which anti-diabetic therapies may also reduce liver-related events in patients with #MASLD.
Read the full study here: https://bit.ly/4s40EgD
Understanding MASLD: The Increasing Rise of Metabolic Liver Disease Explained by Dr. Karen Jerome-Zapadka #United_States #Liver_Disease #MASLD #Cranberry_Township #Dr._Jerome-Zapadka
The April 2026 issue of @lancetgastrohep.bsky.social is out today at www.thelancet.com/gastrohep
This month's issue features content on #IBD, #cirrhosis, #pancreaticcancer, #viralhepatitis, #MASLD + more...
#GastroSky #MedSky #LiverSky
#MASLD in kidney transplant recipients #KTR is associated with worse patient and graft survival
www.kireports.org/article/S2468-0249(26)02...
#transplant #medicine #nephrology
➡️ Nearly 1 in 3 #MASLD patients missed fibrosis risk–based care. Our study shows how AI-augmented workflows could reduce these gaps by automating steatosis detection, FIB-4 scoring, and referral alerts.
🔗 https://ow.ly/9T4u50YrxM2
🏷️ #FeaturedArticle
🧪 Did you know that 1 in 5 people living with #T2D have a degree of #fibrosis?
Prof. Kenneth Cusi urges clinicians to screen for and prevent #MASLD from progressing to cirrhosis #ADAConsensusReport.
📺 Watch the latest #ExpertInsights episode now: easd-elearning.eu/episode/361/...
#Liverhealth
Prenatal prednisone exposure promotes #MASLD in offspring via #GR-HDAC3-mediated #Serpina3c suppression, activating the #Chymase-AngII-AT1R axis to disrupt lipid metabolism, marking #Serpina3c as a critical #TherapeuticTarget.
#STTT #OpenAccess: doi.org/10.1038/s413...
#MASLD patients’ Health Literacy Questionnaire data were analyzed with clinical/demographic data. This suggested that lower health literacy is associated with more advanced MASLD/metabolic dysfunction.
🔗 https://ow.ly/HSjp50YrxF8
🏷️ #EditorsEssentialReading
#FIB-4 is widely used for #fibrosis assessment. But what about its changes over time?📈
🌏 A large international study shows how dynamic #FIB-4 may predict fibrosis progression and clinical outcomes in #MASLD
💡 Interesting implications for clinical practice!
📖: www.sciencedirect.com/science/arti...
#MASLD and #HBV overlap tackled in this article - lots of questions remaining in how to assess and treat this emerging dual threat to global #liver health 🧪
#MedSKy #LiverSky #HepSky #hepatitis
hepatologyforum.org/article/257
Adiposidad paterna en exceso antes del embarazo se asocia con mayor probabilidad de hepatopatía esteatósica asociada a la disfunción metabólica en los descendientes mediada por el IMC infantil en exceso #parents #MASLD gut.bmj.com/content/earl...
Webinar Series promotional graphic from EASD Early Career Academy. It lists: Date - 5 March 2026, 16:30 CET; Guest - Prof. Amalia Gastaldelli, National Research Council, Italy; Topic - “Could we change the course of MASLD - what is available and what is in the pipeline?” The EASD logo appears at the bottom left and the website easd.org/academy at the bottom right.
🎥This week, our EASD Early Career Academy is hosting a #webinar w. Prof. Amy Gastaldelli, co-author of the @easlnews.bsky.social Guidance on the full steatotic #liverdisease trajectory on #MASLD: treatments & what's next.
📅 5 March 2026 |🕛 16:30 CET
👉 Register now: us06web.zoom.us/webinar/regi...
#microbiome #MASLD #health #SDGs
The neonicotinoid pesticide nitenpyram
damages the intestinal mucosa,
disturbs intestinal flora,
and increases Desulfovibrio gut microbiota.
Excessive H2S produced by Desulfovibrio
causes non-alcoholic steatohepatitis.
.
www.sciencedirect.com/science/arti...
Honoured to receive the 🏅 Best Poster Presentation award 🏅at the #EASL #SLDSummit 2026 in Budapest 🇭🇺
A great opportunity to present and discuss data on platelet behaviour in #MASLD within an international scientific setting. Many thanks to all collaborators! 🙌
Presented data from my study at the #EASL #SLDSummit 2026 in Budapest 🇭🇺
I shared insights on #platelet activation and function 🧪 across different stages of #MASLD
A valuable opportunity for discussion and scientific exchange ✨️
Biomarker Liver Fibrosis
Indian #T2DM + #MASLD cohort n=789
FIB-4 & NAFLD Fibrosis Score performed poorly (sensitivity ~22%) vs FibroScan/Vibration-controlled transient elastography for advanced fibrosis (LSM≥9.7 kPa)
#DiabetesMetabSyndr 2026
www.sciencedirect.com/science/arti...
Given the association of #MASLD with cardiovascular, renal, and endocrine metabolic disorders, should cardiovascular-kidney-metabolic syndrome evolve to metabolic-associated liver-cardiovascular-kidney syndrome?
👉 buff.ly/BfSXQvW
#EndoSky #MedSky
#MASLD increases #PDAC risk & #livermetastasis by creating an #immunosuppressive niche driven by the MIF–CD44 axis, which enhances PDAC cell migration, stemness, and adhesion, while MIF inhibition reduces #metastasis, highlighting a targetable pathway.
#STTT: doi.org/10.1038/s413...
Info about MASLD: Metabolic dysfunction-associated steatotic liver disease involves fat accumulation in the liver, which may cause liver inflammation. Obesity and type 2 diabetes are the main risk factors.
Metabolic dysfunction–associated steatotic liver disease (#MASLD) involves accumulation of fat in the liver and may progress to liver inflammation and scarring (#fibrosis).
Learn more in this JAMA Patient Page: ja.ma/4tTZrtD
🔥HOT TOPIC in #LiverTransplantation
This clinical trial shows that a structured, supervised exercise program significantly improves brain blood flow & cognitive function in patients with #MASLD, revealing powerful benefits that extend well beyond the #liver.
📙Full study: https://bit.ly/3NVFMZX
EASD Early Career Academy Webinar Series promotional graphic. Date: 5 March 2026, 16:30 CET. Guest: Prof. Amalia Gastaldelli, National Research Council, Italy. Topic: Could we change the course of MASLD - what is available and what is in the pipeline? EASD Early Career Academy logo bottom left, easd.org/academy bottom right.
📢 How much can we change the course of #MASLD?
The EASD #EarlyCareer Academy is hosting Prof. Amalia Gastaldelli for a new #webinar covering the science behind the #disease, where treatments stand & what's in the pipeline.
📅 5 March 2026 | 🕛 16:30 CET
🔗👉 Register: us06web.zoom.us/webinar/regi...
Wee1-AS, a #lncRNA, protects against #MASLD by repressing #Wee1 and stabilizing #CYCLINB1 to activate CDK1-driven mitochondrial #FattyAcidOxidation, while WEE1 inhibition or the human homolog LNC106435.1 similarly improves mitochondrial function.
#STTT: doi.org/10.1038/s413...
Más info: cimus.usc.gal/es/noticias/...
#RedCIGUS #FondosEuropeos @usc.gal #InvestigaciónBiomédica #Transferencia #fibrosishepática #MASLD
El 70% de las personas con diabetes tipo 2 tienen hígado graso (MASLD) — y casi nadie lo sabe. Explico qué es, cómo progresa en silencio y cómo detectarlo con un análisis rutinario. 🔗 🔗 pormeracuriosidad.com/higado-graso #MASLD #DiabetesT2
Serpina3c mitigates prenatal prednisone exposure-induced #MASLD susceptibility in offspring by modulating hepatic lipid metabolism & inflammatory pathways, highlighting it as a #TherapeuticTarget to reverse adverse #MetabolicProgramming. #Medsky
#OpenAccess: doi.org/10.1038/s413...
✍️ “When the liver fails, the brain does not escape the consequences,” shares Dr Anna Hadjihambi (@KingsCollegeLon). She & her lab are researching how #MASLD affects the brain & the #Ageing process. Read the blog to learn more 🔗 buff.ly/9ctxYSk #LiverDisease
脂肪肝って、フォアグラなの？フォアグラが悪化するとどうなるのか…筆者が〈MRエラストグラフィ〉で肝臓を直視しました！
体を…いや腹を張っての取材です😅
#脂肪肝 #MRI #MASLD #ALD #MASH
jbpress.ismedia.jp/articles/-/9...
A progressive subset of #MASLD, metabolic dysfunction-associated steatohepatitis (MASH), poses an immense and growing clinical and economic burden worldwide because of its risk of progression to advanced fibrosis, cirrhosis, and hepatocellular carcinoma www.thelancet.com/journals/lan...
#OpenAccess
